Navigation Links
Virent Announces New Leadership and Board Appointments
Date:7/15/2010

MADISON, Wis., July 15 /PRNewswire/ -- Virent Energy Systems, Inc. announced today that Susan Healy has been named Chief Financial Officer and Shell executive, David Jacober, has been elected to the company's Board of Directors.

Ms. Healy was most recently Senior Vice President and CFO at Lands' End, the international apparel retailer.  She also served as CFO of Goldman Sachs's power asset business, helping to grow its asset portfolio more than six-fold over three years.  With over 18 years of finance experience, including positions in corporate treasury and investment banking at Goldman Sachs and Lehman Brothers, Ms. Healy has raised over $8 billion and executed $25 billion of M&A transactions across a variety of industries.  She earned a BS in Business Administration from California State Polytechnic University and a JD from Harvard University.

Ms. Healy will have responsibility for the company's financial, accounting, and information technology operations.  She will report to Lee Edwards, President and CEO.

Virent's new Board Member, David Jacober, is the Business Opportunity Manager – Americas Team Lead at Shell Downstream, Inc., where he leads the development and implementation of large, strategic capital projects for process safety, growth, and energy conservation across Shell's global Downstream Manufacturing assets.  Mr. Jacober has over 30 years of refining experience with Shell Oil Company and holds a BS in Chemical Engineering from the University of Illinois.

"Virent is fortunate to add two knowledgeable and experienced leaders in their respective fields.  Susan Healy brings a strong track record in financial leadership including capital-raising, treasury and deal making, to help build our financial foundation essential for the successful commercialization of Virent's innovative BioForming® technology platform," said Lee Edwards, Virent's President and CEO.  "With decades of petroleum refining and distribution expertise, David Jacober adds a valuable perspective of large capital projects to Virent's Board.  His knowledge of global refining, chemicals and transportation fuels will be indispensable to the successful market introduction of Virent's fungible renewable hydrocarbon products."

About Virent Energy Systems

Virent's BioForming process is a leading technology for the production of sustainable advanced biofuels, including biogasoline, diesel, and jet fuel, and many chemicals.  The process has won numerous technology and innovation awards including the U.S. Environmental Protection Agency's Presidential Green Chemistry Challenge and the World Economic Forum's Technology Pioneer awards. Virent has 80 employees and a state of the art catalytic biorefining development facility located in Madison, Wisconsin.  Virent counts premier, global companies Cargill, Shell, and Honda, among its investors.  The BioForming technology is based on the patented Aqueous Phase Reforming process.  To learn more, visit: www.virent.com.

Notes to Editors:

Recent Virent press releases are available at:

www.virent.com/News/press_releases.html

Virent press kit materials and images are available at:

www.virent.com/News/mediakits.html


'/>"/>
SOURCE Virent Energy Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... -- Research and Markets has announced the addition of ... their offering. ... The report provides separate comprehensive analytics for the US, ... World. Annual estimates and forecasts are provided for the period 2015 ... markets. Market data and analytics are derived from primary and secondary ...
(Date:2/17/2017)...  If only one in every hundred cells ... to chemotherapy, thousands of cancer cells would remain ... finding these mutations in ever-smaller subpopulations of tumor ... in blood — to guide treatment decisions and ... however, detecting these genetic anomalies may be more ...
(Date:2/16/2017)... ... ... EIT Digital has launched work to develop a new Smart IOT ... to get under way for the framework, which is designed to reduce the use ... to be transferred eventually to other industries that also require efficient IoT and management ...
(Date:2/16/2017)... PARK, Calif. and GREENWICH, ... Capital, a private investment firm focused on venture ... announced the promotion of Josh Richardson , ... focuses on investments in biotechnology companies.  He is ... has played important roles in Longitude,s investments in ...
Breaking Biology Technology:
(Date:2/3/2017)... SAN ANTONIO , Feb. 3, 2017  Texas Biomedical ... Dr. Larry Schlesinger as the Institute,s ... of Texas Biomed effective May 31, 2017. He is currently ... and Director of the Center for Microbial Interface Biology at ... Dr. Schlesinger as the new President and CEO of Texas ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
(Date:2/2/2017)... 1, 2017  Central to its deep commitment ... worldwide, The Japan Prize Foundation today announced the ... pushed the envelope in their respective fields of ... scientists are being recognized with the 2017 Japan ... only contribute to the advancement of science and ...
Breaking Biology News(10 mins):